Coronavirus Cure

Convalescent Plasma Therapy is an experimental procedure where plasma from the blood of a recovered COVID-19 patient is transfused to a critically ill coronavirus patient. The blood of a person who has recovered from COVID-19 develops antibodies. When injected into the blood of another patient, these antibodies are supposed to help that person fight the infection.

The bacillus Calmette-Guerin, or BCG, shot has been used widely for about 100 years, with a growing appreciation for its off-target benefits. Not only is it a common immunotherapy for early-stage bladder cancer, it also seems to train the body’s first line of immune defense to better fight infections.

When the blood reaches these curves, it makes changes to its fluid mechanics and interactions with the vessel wall. In a healthy person, these changes are in harmony with the tortuous microenvironment, but when diseased, these environments could lead to very complex flow conditions that activate proteins and cells that eventually lead to blood clots.